| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1993-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c44db8051182e5a112bae82e9f37895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_385967a9c42bb29f1d1643b074d8af57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c978d9e965b6e65926bf396cf1c031f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3d59284bd1e6a2cea7478dcd4a058c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12fefe214b4aec6f2fcdab15a1428948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87e76736b29eec2c6881db3df5e0ae1 |
| publicationDate |
1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2109932-A1 |
| titleOfInvention |
Isoindazole compound |
| abstract |
ABSTRACT OF THE DISCLOSURE An isoindazole compound of the formula (1) or a salt thereof; a method for the production thereof; and pharmaceutical use of the compound and a salt thereof, particularly as an angiotensin II antagonist and as an agent for the prophylaxis and treatment of circulatory diseases (particularly hypertension and heart failure); (1) wherein Q is a heterocyclic derivative of the formula (2) or (3) (2) (3) wherein other symbols of the above formulas are as defined in the Specification. The compound and its salt show superior angiotensin II antagonism and are low toxic. Accordingly, they are useful as angiotensin II antagonists for the treatment or prophylaxis of angiotensin II-mediated diseases such as circulatory diseases of hypertension (e.g. essential hypertension, renal hypertension) and heart failure. |
| priorityDate |
1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |